CN Patent

CN116789639A — Mavorixafor的纯化方法、其盐及有关物质

Assigned to China Pharmaceutical Industry Research Institute Co ltd · Expires 2023-09-22 · 3y expired

What this patent protects

本发明公开了Mavorixafor的纯化方法、其盐及有关物质。本发明具体公开了一种化合物1的纯化方法、其硫酸盐及其有关物质化合物2和化合物3。通过将待纯化的化合物1产品形成硫酸盐可以改善其纯度，有效降低所含化合物2和化合物3的含量。

USPTO Abstract

本发明公开了Mavorixafor的纯化方法、其盐及有关物质。本发明具体公开了一种化合物1的纯化方法、其硫酸盐及其有关物质化合物2和化合物3。通过将待纯化的化合物1产品形成硫酸盐可以改善其纯度，有效降低所含化合物2和化合物3的含量。

Drugs covered by this patent

Patent Metadata

Patent number
CN116789639A
Jurisdiction
CN
Classification
—
Expires
2023-09-22
Drug substance claim
No
Drug product claim
No
Assignee
China Pharmaceutical Industry Research Institute Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.